Thanks for the response; you are completely right - the company is a hidden Gem.
Embx does not release any prospective revenue & earnings predictions for 99. But they state that they want to keep the company profitable and to continue to expand....
The predictions & Analysis should be provided by a brokerage firm. Unfortunately, EMBX is not discovered (yet) by any of them ...
Based on the past performance, one should expect continuous growth - although not with the speed of the past years (the US market is almost saturated). The penetration into South America, Europe, and Asia will - if it happens - have HUGE potential! Also positive is that the company just starts to profit from the US market. Until now they had high costs because they had to provide the injection systems to the breeders (this was actually a loss!) - now the systems are up and running and each egg that is sticked by the machine is money in embx's pocket!. One should keep this in mind that they set up the machines for a (calculated) loss, they just started to be profitable.
Another factor are the vaccines! As soon as they come up with a new marketable agent, developed by their own research dept. (this is certainly a long way to go) and produced under embx label, the stock will skyrocket!
IMO, the stock is ready for takeoff. The problem is the timing. The trigger will be pulled - either because of initiated coverage, big company news (vaccines, earnings, etc.), or just because more and more people discover the stock ...
Good luck,
Z. |
